News | August 25, 2010

TCT Offers PFO Summit, Nurse, Tech Symposium

August 25, 2010 – There will be special tracks available for nurses and technologists and for the transcatheter treatment of patent foramen ovale (PFO) during the Transcatheter Cardiovascular Therapeutics (TCT) meeting Sept. 21-25, 2010, in Washington, D.C.

TCT for Nurses and Technologists

The 19th Annual Cardiovascular Nurse and Technologist Symposium is being expanded this year to one and a half days. The extended track will better provide a forum for discussion of the latest advances in interventional, pharmacologic, structural heart and endovascular strategies for the management of the cardiovascular patient. Content is presented utilizing didactic lectures, case presentations, panel discussions, hands-on cadaver heart workshops and breakout sessions.

New PFO Summit

Co-organized by the PFO Research Foundation and the Cardiovascular Research Foundation (CFR), this pre-TCT gathering is designed for physicians, industry, research sponsors, regulators and patient advocates. It will allow an exchange of knowledge and develop initiatives in research, education, definition of care standards and patient registries. Experts with diverse perspectives in PFO science will offer a day of presentations, panel discussions, debates and working groups. This is not a passive continuing medical education meeting, but rather a summit for action to advance patient care. The PFO Summit will take place Monday, Sept. 20, from 9 a.m. to 6 p.m. in the Walter E. Washington Convention Center.

For more information: www.tctconference.com


Related Content

Feature | Cath Lab | Kyle Hardner

Since receiving FDA approval in 2016, intravascular lithotripsy (IVL) systems have grown in popularity among ...

Home November 14, 2025
Home
News | Cath Lab

Nov. 11, 2025 — FastWave Medical has successfully completed enrollment in its 30-patient coronary feasibility study and ...

Home November 13, 2025
Home
News | Cath Lab

Oct. 28, 2025 — Results from the first-of-its-kind randomized PROCTOR trial found that a strategy of saphenous vein ...

Home November 04, 2025
Home
News | Cath Lab

Oct. 27, 2025 — Results from the PREVUE-VALVE study suggest that there are currently at least 4.7 million people aged 65 ...

Home October 29, 2025
Home
News | Cath Lab

Oct. 25, 2025 — Medtronic plc has announced the launch of the Stedi Extra Support guidewire, designed to enhance ...

Home October 28, 2025
Home
News | Cath Lab

Oct. 27, 2025 — Elixir Medical, a developer of technologies to treat cardiovascular disease, has announced new clinical ...

Home October 28, 2025
Home
News | Cath Lab

Oct. 22, 2025 — Heartflow, Inc. has introduced Heartflow PCI Navigator, the newest addition to the Heartflow One ...

Home October 23, 2025
Home
News | Cath Lab

Oct. 15, 2025 — Stereotaxis recently announced it has obtained CE Mark in Europe and submitted a 510(k) application to ...

Home October 16, 2025
Home
News | Cath Lab

Oct. 7, 2025 — Medtronic has announced the full distribution of the Neuroguard IEP System (Neuroguard) after a ...

Home October 07, 2025
Home
News | Cath Lab

Sept. 22, 2025 — Nicklaus Children's Heart Institute in Miami, Florida, is now offering bedside transcatheter patent ...

Home September 23, 2025
Home
Subscribe Now